Vera Therapeutics Raises $261M Through Public Equity Offering
- bancheta6
- Dec 18
- 1 min read
Brisbane, CA, December 09, 2025 (Globe Newswire) -- Vera Therapeutics announced the pricing of an underwritten public offering of just over 6.1 million Class A shares at $42.50 per share, generating approximately $261 million in gross proceeds before fees. The company also granted underwriters a 30-day option to purchase up to an additional 920,716 shares, which could further increase the total raise. Proceeds are expected to support Vera’s late-stage clinical development programs, with the offering set to close on December 11, subject to customary conditions.
Read full article here.